Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2019-10-15
2021-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Training in Parkinson Study
NCT02920632
Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.
NCT02731170
Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease
NCT06323278
The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients
NCT02727257
Cognitive Training in Parkinson's Disease
NCT05495997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the treatment arm only, patients will have the Neuronation application installed on their personal technology device (smartphone or tablet) and are asked to complete 4 training session three times a week. Each session is composed of 5 exercises from one out of 4 cognitive domains: Memory, Attention, Speed and Reasoning. The training is tailor made, the complexity of the exercises is adjusted online, based on the patient's performance.
Participants are re-assessed at the end of the 6-week cognitive training (T1) to find out its effects on cognition and motor ability. The same assessment is administered also after 1 (T2) and 3 (T3) months from the end of the cognitive training to test long-term effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Online cognitive training
6-week online personalized cognitive training using Neuronation platform 4 training session three times a week. Each session is composed of 5 exercises from one out of 4 cognitive domains: Memory, Attention, Speed and Reasoning
Neuronation
Online cognitive training app, with exercises created for patients with mild cognitive impairment
Aspecific online games
online application not created with a cognitive training purpose, for the same amount of time and frequence as the experimental group
Aspecific online games
Online gaming without cognitive training
No online cognitive training
normal clinical follow-up without cognitive training or gaming
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuronation
Online cognitive training app, with exercises created for patients with mild cognitive impairment
Aspecific online games
Online gaming without cognitive training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active presence of a caregiver to help with the use of the App
* Sufficient physical ability to use a technological device
* Signature of informed consent
Exclusion Criteria
* Presence of pathologies of the Central Nervous system potentially associated with cognitive deficits
* No access to internet connection
* Cognitive rehabilitation within the previous 6 months
* Major depression (assessed by Beck Depression Inventory at baseline)
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi di Brescia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Pilotto
Neurology Department Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandro Padovani, Prof
Role: PRINCIPAL_INVESTIGATOR
Università degli Studi di Brescia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology ASST Spedali Civili Brescia
Brescia, Lombardy, Italy
Parkinson's disease Rehabilitation Centre
Trescore Balneario, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.